详细书目
| 文件类型: | 书 |
|---|---|
| 所有的著者/提供者: |
Cynthia Robbins-Roth |
| ISBN: | 0738202533 9780738202532 |
| OCLC号码: | 44078478 |
| 注意: | Includes index. |
| 描述: | xv, 253 p. : ill. ; 24 cm. |
| 内容: | Part 1 The Roots of Biotechnology -- Biotech in the Beginning -- Genentech: The Leader of the Pack -- The Amgen Story -- An Exception to Every Rule: Genzyme -- The Other Biotech: Monoclonal Antibodies -- Part 2 Biotechʼs Building Blocks -- Biotech Star Wars -- The Human Genome Project -- Tools for Genome Studies: BioChips and Microarrays -- Treating Disease at the Gene: Antisense Drugs -- Gene Therapy -- Following the Path of Communication: Signal Transduction -- Brand-New Knees: Tissue Engineering and Cell Replacement -- Building New Drugs: Combinatorial Chemistry -- Agricultural Biotechnology -- Part 3 The Business of Biotech: Product Development and Financing -- The Drug Development Process: From Test Tubes to Patients -- Speed Bumps and Brick Walls: Clinical Trial Design -- Biotech Bankers -- Initial Public Offerings -- Creative Financing -- Corporate Partners and the Urge to Merge -- Part 4 Biotech Stocks -- The Biotech Stock Landscape -- Picking the Right Stocks -- Appendix A Biotech Timeline -- Appendix B Biotechnology-Derived Products on the Market -- Appendix C Biotech Web Sites and Resources -- Appendix D BioVenture Consultantsʼ Biotech Stock Report. |
| 责任: | Cynthia Robbins-Roth. |
摘要:
It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the ʼ70s to todayʼs heyday of new solutions and breakthrough treatments.
标签
添加标签 目的是为 "From alchemy to IPO : the business of biotechnology".
争取是第一个!

